Skip to content

Other news


Back to news

Aquis Stock Exchange Weekly Highlights 18/8/23



August 18, 2023

Most recent

Tap Global Group Plc provided a trading update for the twelve months ended 30 June 2023.
• FY23 Revenue: £2.52m* (FY 2022: £0.90m) up 179%.
• Registered users up 28% since April trading update, taking total to 185,000.
• 5 new cryptocurrencies listed on platform since April trading update, taking total to 44.
David Carr, Chief Executive Officer of Tap Global, commented: “2023 has been a pivotal year for Tap. To have successfully listed on Aquis and to have delivered a record year for revenue, despite the sectoral headwind, demonstrates that we have a product with broad appeal in the fintech space. With Kriya and David in place, I believe we now have the optimal team to drive Tap quickly towards sustained growth and into new markets.” Read more…
Ananda Developments plc announced that the Chief Scientist Office ("CSO"), which is part of the Scottish Government Health Directorate and is responsible for funding research in NHS Scotland (NHS) is providing the non-dilutive funding for the previously announced endometriosis randomised controlled trial using Ananda's MRX1 sublingual cannabidiol oil. The CSO is providing £300,000 to conduct the trial using Ananda's patent pending MRX1 formulation and matching placebo.
Melissa Sturgess, CEO of Ananda, commented "Our objective is to have MRX1 included by the NHS as an efficacious and cost-effective treatment for pain associated with endometriosis. Getting NHS funding for this trial using MRX1 is a clear statement of the importance of endometriosis as a public health issue and we believe clearly demonstrates the interest in the use cannabidiol as a potential treatment for endometriosis and other complex chronic inflammatory pain conditions by the UK's public health bodies.” Read more…
SuperSeed Capital announced results for the Q2 and the six months ending 30 June 2023.
Financial Highlights for Q2 2023:
• NAV per share has grown by 21.7% in H1 2023 and, within this, Q2 was up by 12.6% on Q1 to £1.18.
• IRR on portfolio investments since IPO has increased to 35%.
• Available cash and prepaid investment commitments of £270,546 at 30 June 2023.
Portfolio and Investment Highlights:
• Transaction to sell Techsembly to Sabre was completed on June 30th contributing to H1 NAV growth, with cash of £96,542 received shortly after H1 end. IRR on investment was in excess of 40%.
• Offer for the purchase of another portfolio company received in quarter, with expectations that the transaction will close in Q3. Expected profit from this transaction has been included in the Q2 results.
• Portfolio SAAS revenue growth continued in Q2 2023, with quarter-on-quarter Annual Recurring Revenue ("ARR") growth across the portfolio of the Fund up by 21% over the previous quarter (Q1 2023) and overall SaaS ARR growth in H1 2023 up 37% on the previous financial year-end.
• Two new AI/SaaS companies added to the portfolio - Ankra and Octaipipe.
Read more…
Marula Mining provided an update on the Kinusi Copper Mine where the Company has received a final report on the Phase 1 Program of exploration activities which was completed by the Company’s geological consultants, Geofields Tanzania Limited (“Geofields”) in Q2 2023.
The company says the report has confirmed the preliminary findings (of the identification of a copper mineralised corridor at Kinusi that extends for over 1 kilometre length and over 300 metres in width at the main Sasimo Prospect and with field observations by Geofields suggest visible copper grades of up to 30%. Based on the Phase I Program of exploration activities, Geofields have estimated an initial Exploration Target at Kinusi of a 10-15 million tonnes (“Mt”) deposit of high-grade copper, gold, and other base metals, with the potential to increase to in excess of 50Mt on completion of definitive resource drilling programs to now be implemented by the Company. Read more…
Back to news


  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal